Narrow search
Showing 1 - 10 of 155
Cover Image
Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease : a novel cost-utility modeling study reflecting evidence-ba...
Schmidt, Ralph; Majer, Istvan; Román, Natalia García; … - In: Health economics review 7 (2017) 47, pp. 1-8
children with congenital heart disease (CHD). This study estimated the cost-effectiveness of palivizumab prophylaxis versus …
Persistent link: https://www.econbiz.de/10011764192
Cover Image
Cardiovascular drug shortages in Lebanon : a broken heart
Khattar, Georges; Hallit, Jennifer; El Chamieh, Carolla; … - In: Health economics review 12 (2022) 1, pp. 1-2
For nearly 3 years now, Lebanon has been assailed by compounded crises. With the economic instability, the coronavirus pandemic, and the explosion of the Beirut Port on August 4, 2020; the fragile Lebanese healthcare system has found itself at massive risk of a catastrophic public health crisis...
Persistent link: https://www.econbiz.de/10013198765
Cover Image
Methodological considerations in cost of illness studies on Alzheimer disease
Costa, Nagede; Derumeaux, Helene; Rapp, Thomas; … - In: Health economics review 2 (2012) 18, pp. 1-12
Cost-of-illness studies (COI) can identify and measure all the costs of a particular disease, including the direct …, indirect and intangible dimensions. They are intended to provide estimates about the economic impact of costly disease …. Alzheimer disease (AD) is a relevant example to review cost of illness studies because of its costliness.The aim of this study …
Persistent link: https://www.econbiz.de/10009753410
Cover Image
The high cost of celiac disease in an Israeli Health Maintenance Organization
Heymann, Anthony D.; Leshno, Moshe; Endevelt, Ronit; … - In: Health economics review 3 (2013) 23, pp. 1-5
Background: The aim of this study was to identify costs in patients diagnosed with Celiac disease. Methods: This … insuring over two million members. Our cohort comprised 1,754 patients with Celiac disease with a control group of 15 … celiac disease. Costs were compared with patients suffering from other chronic diseases. Results: The total costs of the …
Persistent link: https://www.econbiz.de/10010242235
Cover Image
Economic burden of multiple sclerosis : a cross-sectional study in Iran
Rezaee, Mehdi; Keshavarz, Khosro; Izadi, Sadegh; … - In: Health economics review 12 (2022) 1, pp. 1-10
Background: Multiple Sclerosis (MS) is a chronic debilitating disease that imposes a heavy socioeconomic burden on … burden of the disease, the following suggestions are presented: providing necessary facilities for the production of MS drugs …
Persistent link: https://www.econbiz.de/10012804118
Cover Image
Economic burden of lung cancer in Turkey : a cost of illness study from payer perspective
Cicin, Irfan; Oksuz, Ergun; Karadurmus, Nuri; Malhan, Simten - In: Health economics review 11 (2021) 1, pp. 1-12
Background: This study was designed to estimate economic burden of lung cancer in Turkey from payer perspective based on expert panel opinion on practice patterns in clinical practice. Methods: In this cost of illness study, direct medical cost was calculated based on cost items related to...
Persistent link: https://www.econbiz.de/10012588835
Cover Image
Cost analysis of Chronic Obstructive Pulmonary Disease (COPD) : a systematic review
Gutiérrez Villegas, Celia; Paz-Zulueta, María; … - In: Health economics review 11 (2021) 1, pp. 1-12
Background: Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease with a high prevalence, and high … disease. Methods: Searches were conducted in PubMed, SCOPUS and Web of Science databases for cost studies on COPD published in … English, between the years 2015 and 2020. The search terms were "COPD" OR "pulmonary disease, chronic obstructive", "cost*" OR …
Persistent link: https://www.econbiz.de/10012607300
Cover Image
Comparison of the cost of illness of primary liver cancer between Japan and Taiwan
Wu, Yinghui; Matsumoto, Kunichika; Chen, Ya-Mei; Tung, … - In: Health economics review 10 (2020) 38, pp. 1-7
Background: Primary liver cancer (PLC) is the fifth and second leading cause of death in Japan and Taiwan, respectively. The aim of this study was to compare the economic burden of PLC between the two countries using the cost of illness (COI) method and identify the key factors causing the...
Persistent link: https://www.econbiz.de/10012390966
Cover Image
Economic burden of chronic migraine in OECD countries : a systematic review
Eltrafi, Alyaa; Shrestha, Sunil; Ahmed, Ali; Mistry, Hema; … - In: Health economics review 13 (2023) 1, pp. 1-10
Background Chronic migraine (CM) is a significant neurological condition affecting a substantial portion of the global population. The economic burden of CM includes both direct healthcare costs and indirect costs resulting from productivity losses and intangible impacts on patients' quality of...
Persistent link: https://www.econbiz.de/10014500513
Cover Image
Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases : dosing patterns and related costs in Switzerland from a payers perspective
Zeidler, Jan; Mittendorf, Thomas; Müller, Rüdiger; … - In: Health economics review 2 (2012) 20, pp. 1-8
one prescription for adalimumab, etanercept, or infliximab were identified. All-cause and disease-specific costs, as well …
Persistent link: https://www.econbiz.de/10009752875